3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Neoplasms
3
Sarcoma
2
Prostatic Neoplasms
2
Neoplasms by Site
2
Multiple Myeloma
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Stomatitis
1
Rectal Diseases
1
Pancreatic Diseases
1
Oligodendroglioma
1
Neoplasms, Plasma Cell
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Motor Activity
1
Lung Neoplasms
1
Liver Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphoid
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Inflammation
1
Graft vs Host Disease
1
Gliosarcoma
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Ascorbic Acid
×
Clear all
No trials found.